MIR3118-4

Q-omics provides the consensus-scored MIR3118-4 profile across patient tissues and cancer cell-line models. MIR3118-4 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in PRAD. Additionally, MIR3118-4 RNA expression shows 276 significant gene co-expression associations, with the highest sampling consensus in PRAD. Together, these results highlight PRAD as cancer lineages where MIR3118-4 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes MIR3118-4 survival associations across molecular data types. MIR3118-4 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MIR3118-4 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	PRAD (12)	view →

This table ranks reproducible MIR3118-4 RNA expression–survival associations across cancer types. High MIR3118-4 expression shows unfavorable associations in PRAD. The PRAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .024). Together, the overview and detailed table identify PRAD as the clearest survival context for MIR3118-4 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PRAD	OS	Tertile	All	0.961	0.995	.024	12	view →

Pink = unfavorable, green = favorable. all 1 lineages →

MIR3118-4-PRAD (OS)

Explore this curve interactively →